普通外文研报
Wolfe Med Tools: LAUNCH FEEDBACK…“the bottom signal we’ve all been waiting for” -device investor
研报英文原文证据摘录
Wolfe Med Tools: LAUNCH FEEDBACK…“the bottom signal we’ve all been waiting for” -device investor
Life Science Tools & Diagnostics
Bioprocessing and Drug Packaging - Market Overweight
Life Science Tools (Diversified) - Market Weight
Specialty Diagnostics - Market Overweight
Wolfe Med Tools: LAUNCH FEEDBACK…“the bottom June 5, 2026
signal we’ve all been waiting for” -device investor
The Wolfe Byte
ICYMI: Wolfe Med Tech -> Wolfe Med Tools with launches on 18 names this week
●Wolfe Med Tools: Test Test Test – This Mike On? Assume Coverage of 12 Tools Stocks
●Wolfe Med Tools: Your New Inbox Cancer – Assume Coverage of 6 Specialty Diagnostics Stocks
Anonymous investor feedback ensues – disclaimer first: We do not intend to initiate a recurring publication of copy-
paste-share direct quotes ahead – hasn’t been part of the library in devices, don’t intend to do that in Tools/Dx.
HOWEVER…Tools/Dx transition a major 1x event – launches precipitate a range of feedback both small & big picture.
Hence our writing here on ‘what we heard’. Did this make us think we started completely offsides/delusional? No (phew).
But there is always a debate/squint/angle/poke…duh! Enjoy. And thank you to those dear readers that contributed :)
Simply wanted to let you know I voted for Mike in II/Extel. I voted for him in Medical Supplies/Devices but thought the
recent Tools launch was fantastic work.
Can you send the backup Excel for the charts in your initiation pack? I thought the returns analysis, constant-dollar
organic revenue growth, etc. were all super interesting.
Huh? Didn’t see this coming
I will say from a secular picture: tools > devices. But tools end markets are so opaque.
Hear you and mostly agree….EV/EBITDA…is the right metric for this group (e.g., DHR pretends to pay taxes on income
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器